Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06980805
PHASE2

A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Sponsor: Immunovant Sciences GmbH

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The study will consist of 3 periods: Period 1: eligible participants will be randomized 1:1 to IMVT-1402 Dose 1 or placebo SC QW for 12 weeks. Period 2: participants who completed Period 1 will receive IMVT-1402 Dose 1 SC QW for 14 weeks. Period 3: after completion of Period 2, participants will be re-randomized 1:1 to blinded IMVT-1402 Dose 1 or Dose 2 SC QW for 26 weeks.

Official title: A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2025-02-19

Completion Date

2027-04

Last Updated

2026-03-25

Healthy Volunteers

No

Interventions

DRUG

IMVT-1402

Dose 1 or Dose 2 SC QW

DRUG

Placebo

Matching Placebo SC QW

Locations (85)

Site Number - 1010

Anniston, Alabama, United States

Site Number - 1020

Birmingham, Alabama, United States

Site Number - 1038

Phoenix, Arizona, United States

Site Number - 1034

Scottsdale, Arizona, United States

Site Number - 1022

Beverly Hills, California, United States

Site Number - 1018

Chula Vista, California, United States

Site Number - 1039

Corona, California, United States

Site Number - 1005

Fremont, California, United States

Site Number - 1023

Los Angeles, California, United States

Site Number - 1000

Aurora, Colorado, United States

Site Number - 1033

Castle Rock, Colorado, United States

Site Number - 1021

Farmington, Connecticut, United States

Site Number - 1014

Hialeah, Florida, United States

Site Number - 1017

Jacksonville, Florida, United States

Site Number - 1028

Miami, Florida, United States

Site Number - 1024

Miami, Florida, United States

Site Number - 1027

Miami, Florida, United States

Site Number - 1011

Miami Lakes, Florida, United States

Site Number - 1025

Orlando, Florida, United States

Site Number - 1009

Buford, Georgia, United States

Site Number - 1030

Brighton, Massachusetts, United States

Site Number - 1019

Auburn Hills, Michigan, United States

Site Number - 1003

Saint Clair Shores, Michigan, United States

Site Number - 1013

Troy, Michigan, United States

Site Number - 1004

Saint Joseph, Missouri, United States

Site Number - 1026

St Louis, Missouri, United States

Site Number - 1007

Charlotte, North Carolina, United States

Site Number - 1008

Durham, North Carolina, United States

Site Number - 1006

Smithfield, North Carolina, United States

Site Number - 1002

Hershey, Pennsylvania, United States

Site Number - 1015

Philadelphia, Pennsylvania, United States

Site Number - 1035

Houston, Texas, United States

Site Number - 1012

Irving, Texas, United States

Site Number -5004

CABA, Argentina

Site Number - 5000

CABA, Argentina

Site Number - 5001

CABA, Argentina

Site Number - 5002

San Miguel de Tucumán, Argentina

Site Number - 5003

San Miguel de Tucumán, Argentina

Site Number - 5601

Sofia, Bulgaria

Site Number - 5603

Sofia, Bulgaria

Site Number - 5600

Sofia, Bulgaria

Site Number - 5605

Sofia, Bulgaria

Site Number - 5606

Sofia, Bulgaria

Site Number - 2000

Calgary, Alberta, Canada

Site Number - 2003

Sarnia, Ontario, Canada

Site Number - 5702

Independencia, Chile

Site Number - 5704

Santiago, Chile

Site Number - 5703

Santiago, Chile

Site Number - 5701

Temuco, Chile

Site Number - 5700

Victoria, Chile

Site Number - 8002

Tbilisi, Georgia

Site Number - 8000

Tbilisi, Georgia

Site Number - 6502

Tübingen, Baden-Wurttemberg, Germany

Site Number - 6500

Erlangen, Bavaria, Germany

Site Number - 6501

Oldenburg, Lower Saxony, Germany

Site Number - 6503

Bochum, North Rhine-Westphalia, Germany

Site Number - 3902

Attiki, Athens, Greece

Site Number - 3901

Athens, Attica, Greece

Site Number - 3903

Thessaloniki, Central Macedonia, Greece

Site Number - 3905

Thessaloniki, Central Macedonia, Greece

Site Number - 3906

Heraklion, Crete, Greece

Site Number - 3900

Attiki, Greece

Site Number - 3904

Larissa, Greece

Site Number - 3004

Poznan, Greater Poland Voivodeship, Poland

Site Number - 3005

Gorzów Wielkopolski, Lubusz Voivodeship, Poland

Site Number - 3000

Warsaw, Masovian Voivodeship, Poland

Site Number - 3001

Warsaw, Masovian Voivodeship, Poland

Site Number - 3006

Rzeszów, Pakistan, Poland

Site Number - 3002

Rzeszów, Podkarpackie Voivodeship, Poland

Site Number - 3003

Lodz, Poland

Site Number-1029

Caguas, Puerto Rico

Site Number - 1037

Ponce, Puerto Rico

Site Number - 1036

San Juan, Puerto Rico

Site Number - 9000

Belgrade, Serbia

Site Number - 9001

Belgrade, Serbia

Site Number - 9003

Novi Sad, Serbia

Site Number - 7104

Badalona, Catalonia, Spain

Site Number - 7105

Pamplona, Navarre, Spain

Site Number - 7101

Burjassot, Valencia, Spain

Site Number - 7100

Madrid, Spain

Site Number - 7102

Madrid, Spain

Site Number - 7103

Málaga, Spain

Site Number - 7002

Leeds, West Yorkshire, United Kingdom

Site Number - 7003

London, United Kingdom

Site Number - 7000

Manchester, United Kingdom